Next-generation sequencing (NGS) has transformed the field of oncology.
Early successes in identifying and targeting oncogenic drivers of solid tumors have set the foundation for genomics guided precision medicine; but, for hematological malignancies, the path to precision medicine is a lot more complex.
Offered Free by: Qiagen
See All Resources from: Qiagen